Article thumbnail

Effect of melatonin on nocturnal blood pressure: meta-analysis of randomized controlled trials

By Ehud Grossman, Moshe Laudon and Nava Zisapel
Topics: Perspectives
Publisher: Dove Medical Press
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2006). Acute effects of oral melatonin administration on arterial distensibility, as determined by carotid-femoral pulse wave velocity, in healthy young men. Exp Clin Cardiol.
  2. (1996). Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials.
  3. (2009). Assessment of the effects of physiological release of melatonin on arterial distensibility and blood pressure. Cardiol Young.
  4. (2011). Association of nighttime hypertension with central arterial stiffness and urinary albumin excretion in dipper hypertensive subjects. Hypertens Res.
  5. (1997). Autonomic nervous system activity in essential hypertension: A comparison between dippers and non-dippers. J Hum Hypertens.
  6. Bioavailability of oral melatonin in humans.
  7. Blood pressure response to melatonin in type 1 diabetes. Pediatr Diabetes.
  8. Blunted nocturnal fall in blood pressure in hypertensive women with future cardiovascular morbid events.
  9. Cardiovascular effects of melatonin in hypertensive patients well controlled by nifedipine: A 24-hour study.
  10. Cardiovascular target organ damage in essential hypertensives with or without reproducible nocturnal fall in blood pressure.
  11. Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension.
  12. (1999). Decreased melatonin synthesis in patients with coronary artery disease. Eur Heart J.
  13. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: Establishing normal and reference values.
  14. (1997). Effect of bedtime melatonin ingestion on blood pressure of normotensive subjects. Blood Press Monit.
  15. (1993). Effect of zolpidem during sleep on ventilation and cardiovascular variables in normal subjects. Fundam Clin Pharmacol.
  16. Effects of melatonin on vascular reactivity, catecholamine levels and blood pressure in healthy men.
  17. (2003). Impaired nocturnal melatonin secretion in non-dipper hypertensive patients.
  18. Impaired nocturnal secretion of melatonin in coronary heart disease.
  19. Influence of circadian time of hypertension treatment on cardiovascular risk: Results of the MAPEC study.
  20. (1998). Influences of melatonin administration on the circulation of women.
  21. (2002). Melatonin and the cardiovascular system. Neuro Endocrinol Lett.
  22. Melatonin attenuates sympathetic nerve responses to orthostatic stress in humans.
  23. (2010). Melatonin for nondippers with coronary artery disease: Assessment of blood pressure profile and heart rate variability. Hypertens Res.
  24. Melatonin in humans.
  25. Melatonin production in hypertensive patients.
  26. (2006). Melatonin reduces night blood pressure in patients with nocturnal hypertension.
  27. Parallel morning and evening surge in stroke onset, blood pressure, and physical activity.
  28. PET and plasma pharmacokineic studies after bolus intraenous administration of [11 c] melatonin in humans.
  29. Plasma concentrations of melatonin in man following oral absorption of different preparations.
  30. (2005). Plasma melatonin concentrations in hypertensive patients with the dipping and non-dipping blood pressure profile. Life Sci.
  31. Potentially beneficial cardiovascular effects of melatonin administration in women.
  32. (1999). Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension.
  33. Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients.
  34. Prolonged melatonin administration decreases nocturnal blood pressure in women. Am J Hypertens.
  35. Reduction of myeloperoxidase activity by melatonin and pycnogenol may contribute to their blood pressure lowering effect.
  36. (2004). Relationship between aortic stiffness and cardiovascular risk factors in a population of normotensives, white-coat normotensives, white-coat hypertensives, sustained hypertensives and diabetic patients. Rev Port Cardiol.
  37. The clinical significance of diurnal blood pressure variations. Dippers and nondippers.
  38. The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis.
  39. (2004). Use of a mild sedative helps to identify true non-dippers by ABPM: A study in patients with diabetes mellitus and hypertension. Blood Press Monit.